Aphex™ Independent Lab Test Data

Killing germs is a serious business. At Aphex™ BioCleanse Systems, we back our products with independent lab testing.  Our products are tested continually in order to assure the high-quality results our customers expect and deserve. At Aphex™ we develop complete protective systems for many industries, and each of our products is put through a rigorous series of tests to maintain our high standards.

 

• Preliminary Antimitotic Efficacy Study of the Provided “Prep-it” Solution Against Trichophyton Mentagrophytes 
• An In-Vitro Time-Kill Evaluation of One Test Product When Challenged with Candida Auris and Candida Albicans 
• Poultry Study: Effects of Bac-D on Hatchability, Conductance, Growth Rate and Feed Conversion on Turkey Poults 
• Poultry Study: Effects of Bac-D on Total Aerobic Bacteria Naturally Found on Broiler Breeder Eggs
• IN-VITRO TIME-KILL EVALUATION WITH VARIOUS BACTERIAL SPECIES
• Human Coronavirus, strain 229E (ATCC #VR-740)
• MRSA: Testing DermAphex against the efficacy of commercially available alcohol based hand sanitizers.
• H1N1: Influenza A (H1N1) virus was used to determine antiviral efficacy of disinfection using DermAphex.
• Rhinovirus 39: Antiviral efficacy study on DermAphex hand sanitizer using a protocol comparable to ASTM E 1053-97.
• Clostridium Difficile: The disinfectant efficacy of DermAphex was tested against Clostridium difficile spores (ATCC 9689).
• NDM-1: DermAphex efficacy was tested against the NDM-1 carbapenem antibiotic resistant strain of Klebsiella pneumoniae.
• PRD-1: The disinfectant efficacy of DermAphex was tested against Bacteriophage PRD-1.
• E.coli: The disinfectant efficacy of DermAphex was tested against E.coli.
• Skin Test: DermAphex was tested its irritancy potential.
• Staphylococcus aureus ATCC-6538 SanAphex Test Results